In this study, we provided compelling data after sEH inhibition evidencing the role of gut dysbiosis in the modulation of peripheral or systemic inflammation, which might reduce neuroinflammation in a mouse model of AD (5xFAD). This evidence concerns the gene EPHX2 and Alzheimer disease.